Medicare Enrolled
Dr. Lev Goldiner, MD
Neurology · New Hartford, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goldiner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldiner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goldiner
Dr. Lev Goldiner is a neurology specialist in New Hartford, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Goldiner performed 1,537 Medicare services across 1,083 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goldiner received a total of $263,872 from 86 pharmaceutical and/or device companies across 1893 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goldiner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 22% volume in NY
$263,872 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,537
Medicare services
Top 22% in NY for neurology
1,083
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~85 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
863 | $60 | $143 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
182 | $82 | $202 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
78 | $96 | $223 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $112 | $265 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
57 | $9 | $40 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
57 | $38 | $88 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
57 | $1 | $9 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
47 | $72 | $157 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
33 | $42 | $627 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
26 | $163 | $426 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
21 | $43 | $720 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $61 | $118 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $43 | $89 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
12 | $123 | $313 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$263,872
Total received (2018-2024)
Avg $37,696/year across 7 years
Top 4% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,893
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$242,151 (91.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,287 (7.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,434 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$16,393
2023
$31,335
2022
$38,509
2021
$48,582
2020
$32,433
2019
$33,659
2018
$62,961
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$6,609
PFIZER INC.
$5,288
Teva Pharmaceuticals USA, Inc.
$437
ARGENX US, INC.
$402
UCB, Inc.
$340
Alexion Pharmaceuticals, Inc.
$315
Eisai Inc.
$313
Otsuka America Pharmaceutical, Inc.
$298
EMD Serono, Inc.
$292
Lilly USA, LLC
$233
SK Life Science, Inc.
$229
Novartis Pharmaceuticals Corporation
$216
Amneal Pharmaceuticals LLC
$214
Sumitomo Pharma America, Inc.
$166
Kyowa Kirin, Inc.
$150
CATALYST PHARMACEUTICALS, INC.
$135
Neurelis, Inc.
$134
TG Therapeutics, Inc.
$131
Lundbeck LLC
$123
Neurocrine Biosciences, Inc.
$80
Biogen, Inc.
$56
ANI Pharmaceuticals, Inc.
$51
MDD US Operations, LLC
$49
JAZZ PHARMACEUTICALS INC.
$42
Celgene Corporation
$29
Takeda Pharmaceuticals U.S.A., Inc.
$24
GENZYME CORPORATION
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Top 3 companies account for 75.2% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$61,254
EMD Serono, Inc.
$42,601
ABBVIE INC.
$38,748
Teva Pharmaceuticals USA, Inc.
$28,799
Allergan, Inc.
$22,149
AbbVie Inc.
$15,358
Avanir Pharmaceuticals, Inc.
$13,778
Biohaven Pharmaceuticals, Inc.
$7,112
Biohaven Pharmaceutical Holding Company Ltd.
$5,744
PFIZER INC.
$5,701
Supernus Pharmaceuticals, Inc.
$4,777
Mallinckrodt LLC
$2,100
UCB, Inc.
$994
Novartis Pharmaceuticals Corporation
$976
SK Life Science, Inc.
$939
Lilly USA, LLC
$894
Alexion Pharmaceuticals, Inc.
$782
Celgene Corporation
$683
Amneal Pharmaceuticals LLC
$676
Biogen, Inc.
$665
ARGENX US, INC.
$631
Amgen Inc.
$589
Genentech USA, Inc.
$510
Eisai Inc.
$427
Lundbeck LLC
$411
Kyowa Kirin, Inc.
$411
Otsuka America Pharmaceutical, Inc.
$403
Adamas Pharmaceuticals, Inc.
$382
Sumitomo Pharma America, Inc.
$341
Neurocrine Biosciences, Inc.
$340
Sunovion Pharmaceuticals Inc.
$297
Mallinckrodt Hospital Products Inc.
$227
Allergan Inc.
$216
LivaNova USA, Inc.
$196
MDD US Operations, LLC
$194
Acorda Therapeutics, Inc
$191
Exeltis, USA Inc.
$190
Neurelis, Inc.
$187
E.R. Squibb & Sons, L.L.C.
$182
EISAI INC.
$168
ANI Pharmaceuticals, Inc.
$162
CATALYST PHARMACEUTICALS, INC.
$153
CSL Behring
$152
Grifols USA, LLC
$138
TG Therapeutics, Inc.
$131
Janssen Pharmaceuticals, Inc
$117
Mallinckrodt Enterprises LLC
$112
ARBOR PHARMACEUTICALS, INC.
$112
UPSHER-SMITH LABORATORIES LLC
$94
Greenwich Biosciences, Inc.
$93
Jazz Pharmaceuticals Inc.
$91
Medtronic USA, Inc.
$80
MITSUBISHI TANABE PHARMA AMERICA, INC.
$78
JAZZ PHARMACEUTICALS INC.
$78
Avion Pharmaceuticals
$76
Flexion Therapeutics, Inc.
$74
Catalyst Pharmaceuticals, Inc.
$72
Impax Laboratories, Inc.
$71
Akcea Therapeutics, Inc.
$70
Boston Scientific Corporation
$69
US WorldMeds, LLC
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
TG THERAPEUTICS, INC.
$45
Arbor Pharmaceuticals, Inc.
$40
Radius Health, Inc.
$37
ACADIA Pharmaceuticals Inc
$27
SANOFI-AVENTIS U.S. LLC
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
BOSTON SCIENTIFIC CORPORATION
$23
GE HealthCare
$22
Alnylam Pharmaceuticals Inc.
$21
PTC Therapeutics, Inc.
$21
Merz North America, Inc.
$21
Medtronic MiniMed, Inc.
$21
Shire North American Group Inc
$20
Horizon Therapeutics plc
$18
IMPEL PHARMACEUTICALS INC.
$18
Assertio Therapeutics, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Vertical Pharmaceuticals, LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
LifeScan, Inc.
$14
IBSA Pharma Inc.
$14
Ultragenyx Pharmaceutical Inc.
$12
Metacel Pharmaceuticals LLC
$12
Top 3 companies account for 54.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Actemra · Aimovig · Austedo XR · BAQSIMI · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · CREXONT · Crysvita · DRIZALMA SPRINKLE · DUOPA · Dhivy · EMFLAZA · EMGALITY · EPIDIOLEX · EVENITY · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GENERAL THERAPIES · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · JARDIANCE · KESIMPTA · KISUNLA · KOSELUGO · KYNMOBI · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · Minimed 670G System · NATPARA · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OT Verio Reflect "One Touch Meter and Strips" · OXTELLAR XR · Ongentys · Ozobax · PANZYGA · PAXLOVID · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · QELBREE · QULIPTA · RADICAVA · RELEXXII · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Tirosint · Trudhesa · Tymlos · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VECTRIS · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · XADAGO · XCOPRI · XEOMIN · Xadago · ZAVZPRET · ZEPOSIA · Zilbrysq · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in NY.
Geographic Context
Neurologists within 10 mi
8
Per 100K population
3.5
County median income
$68,819
Nearest hospital
MOHAWK VALLEY PSYCHIATRIC CENTER
8.2 mi
8.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Goldiner is a clinical cardiology specialist, with above-average Medicare volume (top 22% in NY), with speaking/promotional industry engagement in the top 4% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Goldiner experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Goldiner performed 863 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldiner receive payments from pharmaceutical companies?
Yes. Dr. Goldiner received a total of $263,872 from 86 companies across 1,893 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldiner's costs compare to other neurologists in New Hartford?
Dr. Goldiner's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldiner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in New Hartford
Browse neurologists in New Hartford ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology